News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Hepatotoxicity to Ribociclib is rather common (9% g3/g4) – Dr Sarah Sammons
Photo from dana-farber.org
Jul 14, 2023, 19:34

Hepatotoxicity to Ribociclib is rather common (9% g3/g4) – Dr Sarah Sammons

Hepatotoxicity to Ribociclib is rather common (9% g3/g4). I have had 4 cases now responsive only to steroids after not relenting with cessation alone. Nice case reports below. We need to study this more, seems autoimmune in some cases.

For article: Click here

Source: Dr Sarah Sammons/Twitter

autoimmune cancer case reports Hepatotoxicity OncoDaily Oncology Ribociclib Sarah Sammons
Special Coverage
Blog
Mar 27, 2025, 19:40
Miriam Mutebi: Humbled to host visiting partners AACR to AORTIC-Africa at Aga Khan University Hospital, East Africa
Blog
Mar 27, 2025, 19:23
E. Shyam P. Reddy: Researchers have solved a cellular mystery that may lead to better therapies for colorectal and other types of cancer
Blog
Mar 27, 2025, 19:22
León to Launch Breast Cancer Navigation Program with Experts in June 2025 - City Cancer Challenge
Blog
Mar 27, 2025, 19:17
Mieke Van Hemelrijck: From Brussels to Madrid to Rotterdam – the journey continues
Blog
Mar 27, 2025, 19:15
People, places, and platforms that support a cancer patient’s journey - SPCC
Blog
Mar 27, 2025, 19:06
Peter Leedman: I’m delighted to welcome Professor Joe Trapani AO to the Board of the Harry Perkins Institute of Medical Research
Blog
Mar 27, 2025, 19:05
Zainab Shinkafi-Bagudu: Access to Oncology Medicine aims to close the gap in cancer care in underserved regions
Blog
Mar 27, 2025, 18:58
Barbara Ewals: Why Continuing Medical Education is essential to global health
Blog
Mar 27, 2025, 18:52
Ashraf Abdelghany: ELCC 2025 is here
Blog
Mar 27, 2025, 18:52
Bernard A. Fox: New Cancer Treatment Has Tripled Response Rates for HNSCC
Blog
Mar 27, 2025, 18:49
Isabel Mestres: How City Cancer Challenge can help improve access to cancer care for Indian communities?
Blog
Mar 27, 2025, 18:48
Facing cancer solo? That doesn’t mean you’re alone - ALK Positive